Atezolizumab, CAS [[1380723-44-3]]

Produktübersicht

• Artikelname: Atezolizumab, CAS [[1380723-44-3]]
• Artikelnummer: AMO-M6101
• Hersteller Artikelnummer: M6101
• Alternativnummer: AMO-M6101-5MG,AMO-M6101-10MG
• Hersteller: Abmole Bioscience
• Kategorie: Biochemikalien
• Alternative Synonym: MPDL3280A,Anti-PD-L1,Tecentriq

Produktbeschreibung

Atezolizumab (atezolizumab) is a humanized anti-PD-L1 monoclonal antibody that inhibits PD-L1 signaling with PD-1 and B7-1 and restores tumor-specific T-cell immunity. However, it does not affect the interaction of PD-L2 with PD-1. Atezolizumab reacts with murine PD-L1 (for human and non-humanized mice).

Produkteigenschaften

• Reinheit: >99.0%
• CAS Nummer: [1380723-44-3]
• Target-Kategorie: PD-1/PD-L1